Remarkable Decline in Cervical Cancer Deaths Attributed to HPV Vaccination
Groundbreaking new research reveals that young women vaccinated against the human papillomavirus (HPV) in their early teens have an almost negligible risk of succumbing to cervical cancer before reaching 30. This landmark study, the first of its kind, demonstrates a significant reduction in deaths since the introduction of the school-age vaccination program in 2008, with an estimated 200 lives saved in England to date.
Between 2020 and 2024, no deaths from cervical cancer were recorded among women aged 20 to 24, marking the first time such an absence occurred over a five-year span. This contrasts sharply with an anticipated 23 deaths had the vaccination not been available. Professor Peter Sasieni, lead researcher at Queen Mary University of London, expressed astonishment, stating, "It's incredible to think that a single jab can almost eliminate a particular type of cancer."
Understanding Cervical Cancer and HPV
Cervical cancer remains the 14th most prevalent cancer among females in the UK, with approximately 3,300 new diagnoses annually. The HPV virus, primarily transmitted through close skin-to-skin contact, is believed to be responsible for 99% of these cases. While most HPV infections resolve naturally, some can lead to abnormal cellular changes that may develop into cancer years later.
The study's authors anticipate a continued decrease in cervical cancer fatalities as more vaccinated individuals age. Cancer Research UK, which funded the study, hailed the findings as an "incredible milestone" but also highlighted that vaccination rates in England are currently below recommended targets. Michelle Mitchell, chief executive of Cancer Research UK, emphasized, "We know the HPV vaccine is extremely effective at stopping cervical cancer before it starts and for the first time these findings show it is saving lives."
Alexandra Legg, who was diagnosed with cervical cancer at 30, just before her wedding, advocated strongly for the vaccine. "I'm a real advocate for this vaccine and when Ivy is old enough, she'll be first in the queue," she stated, referring to her daughter born after her treatment.
The Future of Cervical Cancer Elimination
Professor Sasieni described the current reduction in deaths as merely the "tip of the iceberg," foreseeing many more lives saved as vaccinated generations mature. He stressed the importance of maintaining high HPV vaccination levels for ongoing protection.
The UK government has committed to eliminating cervical cancer as a public health concern by 2040. However, recent data from the UK Health Security Agency indicates that only 76% of girls in England were vaccinated by age 15 in 2024-25, falling short of the World Health Organization's (WHO) 90% target for elimination. Cancer Research UK's Michelle Mitchell urged the UK Government and health systems to take targeted action to improve uptake in communities with lower vaccination rates.
Dr. Sharif Ismail of the UK Health Security Agency encouraged young people who missed their vaccination to come forward. Despite the vaccine's success, women aged 25 to 64 are still advised to attend regular cervical screening. Since 2019, boys have also received the HPV vaccine, offering protection against anal, penis, throat, and mouth cancers, and reducing viral transmission.
The Department of Health and Social Care in England acknowledged the study's demonstration of the "extraordinary impact of the HPV vaccination" and affirmed efforts to boost uptake, including catch-up campaigns through community pharmacies. They also mentioned the rollout of HPV self-testing kits for women who have not yet accessed screening.
Source: Young women now have 'close to zero' risk of cervical cancer death after HPV jab